Study shows hemostatic powder improves tissue adhesion and minimizes blood loss in non-compressible hemorrhage models, indicating its potential as a clinical solution.
Uncontrolled hemorrhage remains a critical global health challenge, particularly in cases of non‐compressible bleeding. This study presents a sequentially dual‐crosslinked hemostatic powder that combines rapid hydration‐activated electrostatic gelation with photo‐triggered covalent reinforcement. The powder consists of negatively charged double bond‐functionalized polyacrylic acid (PAA‐db) and positively charged polyethyleneimine (PEI), enabling ultrafast fluid absorption and self‐gelation upon contact with biological fluids. Subsequent light irradiation induces covalent crosslinking, enhancing the mechanical property. The powder‐derived dual‐crosslinked PAA‐db/PEI (dPAA‐db/PEI) hydrogel enables rapid and robust tissue adhesion. In the severe non‐compressible hemorrhage models, the hemostatic powder outperforms clinical hemostatic agents (fibrin glue, CELOX powder), in terms of minimizing hemostatic time and blood loss. This hemostatic powder offers a promising solution for managing severe non‐compressible hemorrhage, demonstrating rapid sealing, robust mechanical performance, and excellent biocompatibility.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: